SEC Form 4 · accession 0001127602-17-018156
HAEMONETICS CORP · HAE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Susan Bartlett Foote
Director
Period of report
May 11, 2017
Accepted (ET)
May 15, 2017 · 8:29 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000313143
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 11, 2017 | M | 7,118 | $34.405 | A | 23,529 | D | |
| Common Stock | May 11, 2017 | M | 8,196 | $36.37 | A | 31,725 | D | |
| Common StockF1 | May 11, 2017 | S | 15,314 | $41.78 | D | 13,251 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-qualified Stock Option (Right to Buy)F2 | $34.405 | May 11, 2017 | M | 7,118 | D | Jul 21, 2012 | Jul 21, 2018 | Common Stock | 7,118 | 0 | D |
| Non-qualified Stock Option (Right to Buy)F2 | $36.37 | May 11, 2017 | M | 8,196 | D | Jul 27, 2013 | Jul 27, 2019 | Common Stock | 8,196 | 0 | D |
Explanation of responses
- F1Represents weighted average of trades between $41.72 and $41.91
- F2Grant to reporting person of right to buy shares of common stock exercisable 100 percent on the first anniversary of the date of grant.